Immunotherapy in Small Cell Lung Cancer

SIMPLE SUMMARY: Small cell lung cancer (SCLC) accounts for about 15% of lung cancers and it has limited therapeutic options and poor prognosis. There has been no real progress for over 30 years in the treatment of this aggressive tumor type and platinum based chemotherapy represented the cornerstone...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Esposito, Giovanna, Palumbo, Giuliano, Carillio, Guido, Manzo, Anna, Montanino, Agnese, Sforza, Vincenzo, Costanzo, Raffaele, Sandomenico, Claudia, La Manna, Carmine, Martucci, Nicola, La Rocca, Antonello, De Luca, Giuseppe, Piccirillo, Maria Carmela, De Cecio, Rossella, Botti, Gerardo, Totaro, Giuseppe, Muto, Paolo, Picone, Carmine, Normanno, Nicola, Morabito, Alessandro
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565004/
https://ncbi.nlm.nih.gov/pubmed/32899891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092522
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky